| Christine Kay, APRN, CNM | |
|
67 Corporate Dr Ste 300, Portsmouth, NH 03801-2847 | |
| (603) 610-8079 | |
| Not Available |
| Full Name | Christine Kay |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | 67 Corporate Dr Ste 300, Portsmouth, New Hampshire |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427373240 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 081016-23 (New Hampshire) | Primary |
| Entity Name | Wentworth Douglass Physician Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447352430 PECOS PAC ID: 5496749848 Enrollment ID: O20040409000433 |
News Archive
Responding to yesterday's Queen's Speech (Tuesday 23 November 2004), Mr James Johnson, chairman of the British Medical Association, warned that legislation to introduce national ID cards must not lead to vulnerable groups being denied access to the NHS.
Counting the amount of a type of normal cell circulating in the blood of people with cancer could predict whether a tumor progresses or responds to therapy, a new study led by the University of Michigan Comprehensive Cancer Center has found. The finding could give doctors an early indication of whether a treatment will be successful, sparing patients months of an ineffective therapy.
A study by J. William Harbour, M.D., associate director for Basic Research and leader of the Eye Cancer Site Disease Group at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, and colleagues published today in Clinical Cancer Research details the discovery of a biomarker that puts patients at a higher risk for metastasis of uveal melanoma.
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced details of its new translational medicine unit in Manchester, UK. The unit is the first deliverable from a collaborative agreement between ICON and the Central Manchester University Hospitals Foundation (CMFT) to develop purpose-built translational medicine facilities on the newly-developed Manchester Royal Infirmary (MRI) campus.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christine Kay, APRN, CNM Po Box 412503, Boston, MA 02241-2503 Ph: (617) 726-3884 | Christine Kay, APRN, CNM 67 Corporate Dr Ste 300, Portsmouth, NH 03801-2847 Ph: (603) 610-8079 |
News Archive
Responding to yesterday's Queen's Speech (Tuesday 23 November 2004), Mr James Johnson, chairman of the British Medical Association, warned that legislation to introduce national ID cards must not lead to vulnerable groups being denied access to the NHS.
Counting the amount of a type of normal cell circulating in the blood of people with cancer could predict whether a tumor progresses or responds to therapy, a new study led by the University of Michigan Comprehensive Cancer Center has found. The finding could give doctors an early indication of whether a treatment will be successful, sparing patients months of an ineffective therapy.
A study by J. William Harbour, M.D., associate director for Basic Research and leader of the Eye Cancer Site Disease Group at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, and colleagues published today in Clinical Cancer Research details the discovery of a biomarker that puts patients at a higher risk for metastasis of uveal melanoma.
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced details of its new translational medicine unit in Manchester, UK. The unit is the first deliverable from a collaborative agreement between ICON and the Central Manchester University Hospitals Foundation (CMFT) to develop purpose-built translational medicine facilities on the newly-developed Manchester Royal Infirmary (MRI) campus.
› Verified 5 days ago
Maribeth Quinn, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: Harbour Women's Health, 155 Griffin Rd, Portsmouth, NH 03801 Phone: 603-431-6011 Fax: 603-431-6227 | |
Catherine A Mclaughlin-hills, CNM, MSN Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: Harbour Women's Health, 155 Griffin Road, Portsmouth, NH 03801 Phone: 603-431-6011 Fax: 603-431-6227 | |
Kristina Alyse Rogers Scherr, CNM, MSN Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 67 Corporate Dr Ste 300, Portsmouth, NH 03801 Phone: 603-610-8079 | |
Joann Demuth, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: Harbour Women's Health, 155 Griffin Road, Portsmouth, NH 03801 Phone: 603-431-6011 Fax: 603-431-6227 | |
Katherine Mahar, NP, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 67 Corporate Drive, Suite 300, Portsmouth, NH 03801 Phone: 603-610-8079 | |
Mrs. Emilie Gray Bergh, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 67 Corporate Dr Ste 300, Portsmouth, NH 03801 Phone: 603-610-8079 |